podcast

Bivalirudin For Angioplasty: Expensive Heparin?+

30th April 2008
Tony Gershlick
tony gershlick Bivalirudin For Angioplasty: Expensive Heparin?

Tony Gershlick
Tony Gershlick, University of Leicester
Adnan Kastrati, Deutsches Herzzentrum, Munich
Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the

…

Read More+

Tropical Health Research: London Scientist Honored+

29th April 2008
Brian Greenwood
brian greenwood Tropical Health Research: London Scientist Honored
Brian Greenwood

Brian Greenwood, London School of Hygiene and Tropical Medicine
Brian Greenwood has won the Hideyo Noguchi Africa Prize for his numerous achievements in tropical disease research. He talked with Derek Thorne about his work, including the pivotal

…

Read More+

Audio Journal of Oncology Volume 16 Number 9+

26th April 2008
Angel Rodriguez

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam

angel rodriquez Audio Journal of Oncology Volume 16 Number 9

Angel Rodriguez

In this edition:

1. Lapatinib: Targets Breast Cancer Stem Cells?

Angel Rodriguez, Baylor College, Houston…

Read More+

Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon+

25th February 2008
Kenneth Anderson
kenneth anderson Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon
Kenneth Anderson

Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008
KENNETH ANDERSON, Dana-Farber Cancer Institute, Boston
Multiple myeloma may soon be considered a chronic disease with cure on the horizon, thanks to an array of novel

…

Read More+

Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer+

15th February 2008
David Cunningham
david cunningham Oral Capecitabine: As Good As Fluorouracil Second Line for Metastatic Colorectal Cancer
David Cunningham
REFERENCE: Abstract 3012, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
DAVID CUNNINGHAM, Royal Marsden Hospital, London
The oral agent capeticabine is just as effective as fluorouracil for treating patients whose metastatic colorectal cancer

…

Read More+

Hormone Refractory Prostate Cancer: Increased Progression-Free Survival With Satraplatin and Prednisone+

1st February 2008
Cora Sternberg
cora sternberg Hormone Refractory Prostate Cancer: Increased Progression Free Survival With Satraplatin and Prednisone
Cora Sternberg
REFERENCE: Abstract 4010, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
CORA STERNBERG, San Camillo and Forlanini Hospital, Rome
Satraplatin could provide a new option for patients with hormone refractory prostate cancer, by giving

…

Read More+

Liver Cancer: Risk Groups for Screening+

27th January 2008
Eugene Schiff
eugene schiff Liver Cancer: Risk Groups for Screening
Eugene Schiff

REFERENCE: General Session IV
EUGENE SCHIFF, University of Miami
Screening for Hepatitits C and B, and subsequent screening for cancer, can save millions of lives from hepatocellular carcinoma. Eugene Schiff told the Gastrointestinal Cancers Conference in Orlando which

…

Read More+

Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer+

27th January 2008
Charles Hsu
charles hsu Adjuvant Chemoradiotherapy: Big Gains In Pancreas Cancer
Charles Hsu

CHARLES HSU, Johns Hopkins University, Baltimore
Big improvements in overall survival were achieved by combining radiation with adjuvant chemotherapy for patients with pancreas cancer in a dtudy reported to the conference in Orlando. Charles Hsu told Peter Goodwin

…

Read More+

Meta-Analysis Proves Statins Help Patients With Diabetes+

11th January 2008
Colin Baigent
colin baigent Meta Analysis Proves Statins Help Patients With Diabetes
Colin Baigent

REFERENCE: Lancet 371:117 January 11, 2008
COLIN BAIGENT, Oxford University
Statins were found to cut cardiovascular event rates by a fifth among patients with both Type I and Type II diabetes in a meta-analysis of 18 000

…

Read More+

Early Breast Cancer Chemotherapy: Long Term Findings+

8th January 2008
Richard Peto
richard peto Early Breast Cancer Chemotherapy: Long Term Findings
Richard Peto

REFERENCE: Lancet 371:29-40; January 5, 2008
RICHARD PETO, Oxford University
The prospect of cutting breast cancer mortality in half throughout the world is held out by Richard Peto of the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). He

…

Read More+

ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up+

15th December 2007
Jack Cuzick
jack cuzick ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up
Jack Cuzick

JACK CUZICK, Wolfson Institute of Preventive Medicine, London
New data from the ATAC trial, which is testing anastrozole and tamoxifen in early breast cancer, have demonstrated the continued superiority of the aromatase inhibitor. Among other things, the data

…

Read More+

New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer+

15th December 2007
Jose Baselga
jose baselga New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
Jose Baselga

JOSE BASELGA, Vall d’Hebron Hospital, Barcelona
RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and

…

Read More+